『VITALS』のカバーアート

VITALS

VITALS

著者： Cloudcast
無料で聴く

VITALS, the pulse of Georgia life sciences, brings together the leaders, the thinkers, the movers, and shakers who are putting Georgia firmly in a leadership position for what is widely known as "the biology century."

These closely curated conversations are led by the President & CEO of Georgia Life Sciences, Maria Thacker Goethe. Whether it is exploring topics from policy matters and venture funding to legislative matters and artificial intelligence, Maria expertly navigates and explores to flesh out actionable information from world class guests.

VITALS is brought to the community by Georgia Life Sciences in conjunction with Cloudcast Atlanta, a division of Cloudcast Media.

About Georgia Life Sciences


About Cloudcast Atlanta and Cloudcast Media2025 生物科学 科学 経済学
エピソード
  • GLS Vitals Episode 12 - Moving Quickly with a Long-Term Strategy: Building a Scrappy Rare Disease Company

    GLS Vitals Episode 12 - Moving Quickly with a Long-Term Strategy: Building a Scrappy Rare Disease Company
    2026/08/13
    WELCOME TO VITALS, THE PULSE OF GEORGIA LIFE SCIENCES

    In this episode Georgia Life Sciences President & CEO, Maria Thacker Goethe, sits down with Dave Penake, CEO of Saol Therapeutics and Chair of Georgia Life Sciences, for a conversation about leadership, biotech growth, rare disease innovation, and the future of Georgia’s life sciences ecosystem.Drawing on a career that has taken him from semiconductor manufacturing to biotech hubs in Boston and the San Francisco Bay Area—and ultimately to Atlanta—Dave shares the experiences that shaped his approach to leadership and his belief in taking a long-term view when building life sciences companies.

    The conversation explores Saol Therapeutics’ evolution and pipeline, including the company’s work in rare disease and pain, as well as the difficult strategic decisions involved in financing, portfolio development, partnerships, and determining when another organization may be better positioned to advance an innovation. Dave also discusses the importance of patient communities and how their experiences continue to motivate the Saol team.

    Maria and Dave then turn to Georgia’s growing life sciences ecosystem. Having worked in Boston and the Bay Area before spending nearly a decade in Atlanta, Dave shares why he sees Georgia’s talent, universities, infrastructure, workforce retention, and quality of life as significant competitive advantages. He also discusses opportunities to strengthen the connection between university innovation, entrepreneurship, capital, company formation, and commercial-scale growth.

    As Chair of Georgia Life Sciences, Dave also shares his priorities for the organization, including executing Georgia’s life sciences roadmap, aligning leaders across the ecosystem, measuring progress, and building greater support for the industry.

    The episode closes with a look at what gives Dave optimism about the future—from accelerating technological advances that could unlock new treatments and cures to growing global competition that may push the U.S. life sciences industry to innovate even faster. In this episode:
    • Building and leading a life sciences company for the long term
    • Advancing therapies for rare diseases and unmet patient needs
    • Making difficult decisions around capital, partnerships, and growth
    • Knowing when to build, partner, license, or hand off an innovation
    • Why Georgia can compete as a leading life sciences hub
    • Connecting university research with entrepreneurs and capital
    • Executing Georgia’s life sciences industry roadmap
    • The future of biotechnology, innovation, and U.S. competitiveness
    About Georgia Life Sciences

    As the leading advocate for the state’s dynamic and diverse life sciences sector, Georgia Life Sciences’ mission is to advance the growth of Georgia’s life sciences industry through partnerships and initiatives that accelerate innovation, investment, and job creation. To accomplish this mission, Georgia Life Sciences conducts economic development activities; advocates on behalf of its members on public policy matters; educates the public about the benefits of life sciences research and product development; and provides a network for idea exchange and cooperation.

    For more information on the impactful work, to join as a member, or provide support to the mission, please visit Georgia Life Sciences at https://www.galifesciences.org/

    About Cloudcast Media

    As the national leader in local podcasting to create a "listen where you live" mindset, Cloudcast Atlanta, a division of Cloudcast Media, proudly produces "VITALS: The Pulse of Georgia Life Sciences" through its CauseCast platform to help amplify, augment, and accelerate the mission and reach of community social impact organizations. For more information on Cloudcast Media, please visit their website at CloudCast Media.

    This episode was produced by Senior Associate Producer Brandon Joe. The episode was recorded, engineered, mixed and mastered by Sky Guides Atlanta, the podcast program and studio affiliated with the Russell Innovation Center for Entrepreneurs (RICE) in Atlanta, Georgia.
    続きを読む 一部表示
    38 分
  • GLS Vitals Episode 11 - Building Tomorrow: Biotech, Innovation, Talent & Growth

    GLS Vitals Episode 11 - Building Tomorrow: Biotech, Innovation, Talent & Growth
    2026/07/28
    WELCOME TO VITALS, THE PULSE OF GEORGIA LIFE SCIENCES

    In this episode of Vitals: Georgia's Life Sciences Podcast, Georgia Life Sciences President & CEO Maria Thacker Goethe sits down with Helen Tarlatin, Director of Employee & Community Engagement at UCB, to discuss one of the most significant life sciences investments in Georgia's history. Fresh off UCB's announcement of its $2 billion biologics manufacturing facility in Gwinnett County, Helen shares why Georgia emerged as the ideal location, what this investment means for patients, and how workforce development, education, and community partnerships are shaping the next generation of biotechnology manufacturing. The conversation explores how industry, education, government, and nonprofits must work together to build the skilled workforce needed to support America's growing life sciences sector. Topics include:
    • Why UCB selected Georgia for its first U.S. branded biologics - manufacturing facility
    • The strategic importance of domestic pharmaceutical manufacturing
    • Building a sustainable life sciences workforce and talent pipeline
    • The role of Georgia's universities, technical colleges, and workforce partners
    • STEM education and inspiring future biotechnology careers
    • Leadership lessons on collaboration, transparency, and community engagement
    • Georgia's emergence as a national hub for biotechnology and advanced manufacturing
    • How public-private partnerships strengthen economic development and innovation
    Whether you're a biotechnology executive, entrepreneur, educator, student, policymaker, or simply interested in the future of healthcare innovation, this episode offers valuable insights into the investments and partnerships transforming Georgia into one of America's leading life sciences ecosystems.

    About Georgia Life Sciences

    As the leading advocate for the state’s dynamic and diverse life sciences sector, Georgia Life Sciences’ mission is to advance the growth of Georgia’s life sciences industry through partnerships and initiatives that accelerate innovation, investment, and job creation. To accomplish this mission, Georgia Life Sciences conducts economic development activities; advocates on behalf of its members on public policy matters; educates the public about the benefits of life sciences research and product development; and provides a network for idea exchange and cooperation.

    For more information on the impactful work, to join as a member, or provide support to the mission, please visit Georgia Life Sciences at https://www.galifesciences.org/

    About Cloudcast Media

    As the national leader in local podcasting to create a "listen where you live" mindset, Cloudcast Atlanta, a division of Cloudcast Media, proudly produces "VITALS: The Pulse of Georgia Life Sciences" through its CauseCast platform to help amplify, augment, and accelerate the mission and reach of community social impact organizations. For more information on Cloudcast Media, please visit their website at CloudCast Media.

    This episode was produced by Senior Associate Producer Brandon Joe. The episode was recorded, engineered, mixed and mastered by Sky Guides Atlanta, the podcast program and studio affiliated with the Russell Innovation Center for Entrepreneurs (RICE) in Atlanta, Georgia.
    続きを読む 一部表示
    38 分
  • GLS Vitals Episode 10 - Building the Future - Biotech Leadership & Global Impact

    GLS Vitals Episode 10 - Building the Future - Biotech Leadership & Global Impact
    2026/06/10
    WELCOME TO VITALS, THE PULSE OF GEORGIA LIFE SCIENCESDavid Dodd, CEO of Geovax, discussed the evolution of Georgia's life sciences ecosystem, emphasizing the persistence and collaboration of various stakeholders over decades. Geovax's focus is on developing the Geo MVA vaccine for monkeypox and smallpox, leveraging a platform with no contraindications. The company aims to establish advanced MVA manufacturing in Georgia, initially employing 25-50 people, expanding to 100+. Dodd highlighted the critical need for sustained investment in vaccine innovation and manufacturing to ensure global health security. He also stressed the importance of education and workforce development in fostering a robust life sciences ecosystem.David Dodd's Journey and Georgia's Life Sciences EcosystemMaria Thacker introduces David Dodd, CEO of Geovax, and highlights his long-standing involvement in Georgia's life sciences community.David Dodd reflects on the persistence and commitment of people in building Georgia's life sciences ecosystem over decades.David emphasizes the importance of resilience, capital scarcity, and long timelines in the biotech industry.Maria and David discuss the evolution of Georgia's life sciences hub, noting increased connectivity and awareness of Georgia's opportunities.David Dodd's Career Path and Personal JourneyDavid Dodd shares his career journey, starting in 1977 with Abbott Laboratories and progressing through various roles in big pharma, including Bristol Myers Squibb and Wyeth.David highlights his experience as CEO of Solvay Pharmaceuticals and his role in transforming the company's value from $100 million to $2.5 billion.David discusses his transition to NASDAQ companies and his involvement with Geovax, eventually becoming its CEO in 2018.David mentions his multiple attempts to retire and his current satisfaction with his work and the support of his wife.Geovax's Evolution and EnduranceDavid explains Geovax's evolution from a single-product HIV vaccine focus to a broader infectious disease vaccine platform.He highlights the relevance of Geovax's vaccine platform, which was used to eradicate smallpox and has been repurposed for other infectious diseases.David discusses the challenges of adapting to changing markets, funding environments, and public health priorities.He emphasizes the importance of disciplined prioritization, scientific credibility, and the ability to adapt in a challenging environment.Manufacturing Challenges and PreparednessDavid elaborates on the infrastructure-intensive nature of vaccine development and the unique challenges of manufacturing vaccines.He discusses the critical role of quality systems, regulatory alignment, and supply chain depth in vaccine manufacturing.David highlights the importance of sustained investment in preparedness between crises to avoid rebuilding capacity during emergencies.He provides examples of the impact of the monkeypox outbreak and the need for a global supply of vaccines.Geovax's Focus on Geo MVA and Clinical TrialsDavid outlines Geovax's current focus on Geo MVA, a vaccine candidate for monkeypox and smallpox preparedness.He explains the expedited regulatory path granted by the European Medicines Agency (EMA) for Geo MVA.David details the manufacturing process and the challenges of producing MVA vaccines quickly.He discusses the company's plans to establish advanced MVA manufacturing in Georgia and the support from state and federal legislators.Georgia's Role in Vaccine Innovation and BiosecurityDavid emphasizes the importance of Georgia's role in vaccine innovation and biosecurity.He highlights the state's potential to become a hub for vaccine innovation and biosecurity, leveraging its academic institutions and growing venture activity.David discusses the need for sustained investment in infrastructure and talent to support the life sciences ecosystem.He mentions the importance of collaboration and integration within the ecosystem to achieve long-term success.Leadership and Decision-Making in BiotechDavid shares his leadership philosophy, emphasizing the importance of execution, science, and talent development.He discusses the challenges of prioritizing multiple global health threats and the need for exquisite focus on critical programs.David highlights the importance of mentoring and staff development in building a strong team.He reflects on the evolution of Georgia's life sciences ecosystem and the role of policy makers and legislators in supporting the industry.Georgia's Life Sciences Ecosystem and Future ProspectsDavid expresses pride in the progress of Georgia's life sciences ecosystem and its potential to become a legitimate life sciences hub.He discusses the importance of long-term planning and investment in education and workforce development.David highlights the need for continued collaboration and support from the state and federal government to achieve the ecosystem's goals.He emphasizes the importance of maintaining ...
    続きを読む 一部表示
    1 時間 14 分
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません